Catalog Number 10317 |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
|
Patient Problem
Hemorrhage/Bleeding (1888)
|
Event Date 07/18/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
Lot number, expiry and manufacture date are not available at this time.Investigation: per the customer, the patient was very ill and it was difficult to identify the root cause of the event.The run data file (rdf) was analyzed for this event.Signals from the rdf showed that the device operated as intended.Investigation is in process.A follow-up report will be provided.
|
|
Event Description
|
The customer reported that during an apheresis procedure, a patient experienced a brain stem hemorrhage.It is unknown at this time if medical intervention was required for this event.Patient identifier, age, and outcome are not available at this time.Patient's gender and weight were obtained from the run data file (rdf).The spectra optia idl set is not available for return because it was discarded by the customer.This product is not available within the us, but this report is being filed due to an alleged failure that could occur on a similarly marketed device platform cleared for use by the fda.
|
|
Manufacturer Narrative
|
This report is being filed to provide additional information.Root cause: based on the available evidence, the root cause for the brainstem hemorrhage was not related to the optia device.The doctor had scheduled a second wbcd for the(b)(6).Signals from the rdf analysis showed no alarms or abnormal procedure behavior.Given this information, the device was found to be operating as intended, and within the generally tolerated limits for a majority of patients.There was no system or device malfunction identified that may have contributed to the adverse reaction reported.
|
|
Manufacturer Narrative
|
This report is being filed to provide additional information.Additional investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.
|
|
Manufacturer Narrative
|
This report is being filed to provide additional information and corrected information.Additional investigation: according to therapeutic apheresis: a physician's handbook, adverse events occur during therapeutic procedures with a frequency of 4.8%.Most complications and patient reactions during therapeutic apheresis procedures are considered minor and well tolerated.Updated root cause: based on the run data file (rdf) analysis, the root cause for the brainstem hemorrhage was not related to the optia device.Furthermore, the physician at the customer's site stated that the acd-a was unlikely related to the hemorrhage.The physician scheduled a second wbcd for (b)(6).The patient¿s hemorrhage is possibly related to the patient¿s disease state and/or patient¿s physiology.
|
|
Event Description
|
Due to (b)(4) privacy laws, the customer was unable to provide patient identifier and outcome.
|
|
Search Alerts/Recalls
|